Hisamitsu Pharmaceutical Co Inc
TSE:4530
Hisamitsu Pharmaceutical Co Inc
EPS (Diluted)
Hisamitsu Pharmaceutical Co Inc
EPS (Diluted) Peer Comparison
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
EPS (Diluted)
¥181
|
CAGR 3-Years
17%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-3%
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
EPS (Diluted)
¥92
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-4%
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
EPS (Diluted)
¥104
|
CAGR 3-Years
39%
|
CAGR 5-Years
17%
|
CAGR 10-Years
2%
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
EPS (Diluted)
¥253
|
CAGR 3-Years
-4%
|
CAGR 5-Years
12%
|
CAGR 10-Years
-1%
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
EPS (Diluted)
¥198
|
CAGR 3-Years
16%
|
CAGR 5-Years
27%
|
CAGR 10-Years
6%
|
|
Astellas Pharma Inc
TSE:4503
|
EPS (Diluted)
¥9
|
CAGR 3-Years
-47%
|
CAGR 5-Years
-39%
|
CAGR 10-Years
-14%
|
See Also
What is Hisamitsu Pharmaceutical Co Inc's EPS (Diluted)?
EPS (Diluted)
181.4
JPY
Based on the financial report for Feb 29, 2024, Hisamitsu Pharmaceutical Co Inc's EPS (Diluted) amounts to 181.4 JPY.
What is Hisamitsu Pharmaceutical Co Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
-3%
Over the last year, the EPS (Diluted) growth was 23%. The average annual EPS (Diluted) growth rates for Hisamitsu Pharmaceutical Co Inc have been 17% over the past three years , -5% over the past five years , and -3% over the past ten years .